Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 318.40
-8.50 (-2.60%)
At close: Jan 30, 2026
Evogene Employees
Evogene had 117 employees as of December 31, 2024. The number of employees decreased by 25 or -17.61% compared to the previous year.
Employees
117
Change (1Y)
-25
Growth (1Y)
-17.61%
Revenue / Employee
226.85K ILS
Profits / Employee
-77.80K ILS
Market Cap
27.76M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 117 | -25 | -17.61% | 117 | 0 |
| Dec 31, 2023 | 142 | 5 | 3.65% | 142 | 0 |
| Dec 31, 2022 | 137 | -4 | -2.84% | 137 | 0 |
| Dec 31, 2021 | 141 | 10 | 7.63% | 141 | 0 |
| Dec 31, 2020 | 131 | -12 | -8.39% | 131 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bonus BioGroup | 37 |
| BioLineRx | 28 |
| Matricelf | 12 |
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 9 |
| Can-Fite BioPharma | 5 |
| BioLight Life Sciences | 4 |
Evogene News
- 25 days ago - Evogene (EVGN) and Unravel Biosciences Partner to Tackle Neurological Diseases - GuruFocus
- 25 days ago - Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders - PRNewsWire
- 4 weeks ago - Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development - PRNewsWire
- 7 weeks ago - EverGen Infrastructure Corp. (EVGN:CA) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 2 months ago - EverGen Infrastructure Corp. (EVGN:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Evogene Ltd. (EVGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Evogene GAAP EPS of -$0.31 beats by $0.10, revenue of $0.31M misses by $0.34M - Seeking Alpha
- 2 months ago - Evogene Reports Third Quarter 2025 Financial Results - PRNewsWire